ArriVent BioPharma (AVBP) Restructuring Costs (2024 - 2026)
ArriVent BioPharma (AVBP) posted Restructuring Costs of $2.3 million for Q1 2026, up 2.21% sequentially from $2.3 million in Q4 2025, and up 7.44% YoY from $2.2 million in Q1 2025.
ArriVent BioPharma (AVBP) Restructuring Costs (2024 - 2026) Analysis & Trends
ArriVent BioPharma has reported Restructuring Costs for 3 years, with the latest figure at $2.3 million in Q1 2026.
- Quarterly Restructuring Costs rose 7.44% year-over-year to $2.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.9 million (up 17.2% YoY) and the FY2025 annual result came in at $8.8 million, up 22.77% from the prior year.
- Restructuring Costs climbed to $2.3 million in Q1 2026 per AVBP's latest filing, from $2.3 million in the prior quarter.
- Over five years, Restructuring Costs peaked at $2.4 million in Q2 2025 and troughed at $1.5 million in Q4 2024.
- A 3-year average of $2.0 million and a median of $2.1 million in 2024 frame the typical range for Restructuring Costs.
- The widest YoY moves for Restructuring Costs: up 54.86% in 2025, down 7.37% in 2025.
- Over 3 years, Restructuring Costs stood at $1.5 million in 2024, then surged by 54.86% to $2.3 million in 2025, then rose by 2.21% to $2.3 million in 2026.
- According to Business Quant data, Restructuring Costs over the past three periods registered $2.3 million, $2.3 million, and $1.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | ArriVent BioPharma | 1.43 Bn | 1.43 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.76 Mn |
| Mar 31, 2026 | 2.31 Mn |
| Dec 31, 2025 | 2.26 Mn |
| Sep 30, 2025 | 1.92 Mn |
| Jun 30, 2025 | 2.44 Mn |
| Mar 31, 2025 | 2.15 Mn |
| Dec 31, 2024 | 1.46 Mn |
| Sep 30, 2024 | 2.08 Mn |
| Jun 30, 2024 | 1.94 Mn |
| Mar 31, 2024 | 1.68 Mn |